Cervical Cancer and Breast Cancer
Conditions
Interventions
Cervical cancer screening:Cervical cancer screening
Breast Cancer Screening:Breast Cancer Screening
HPV vaccination:HPV vaccination: Cecolin
Gardasil
Recombinant Human Papillomavirus Bivalent (Types 16,18) Vaccine (Pichia pastoris)
Sponsors
School of Population Medicine and Public Health, Chinese Academy of Medical Sciences Peking Union Medical College
Eligibility
Sex/Gender
Female
Age
11 Years to 64 Years
Inclusion criteria
Inclusion criteria: (1) Girls who aged 11-13 in the project areas (2) Women aged 35-64 in the project areas who have intact cervix, understand the project procedures, voluntarily participate in cervical cancer screening, and sign the informed consent. (3) Women aged 35-64 in the project areas who understand the project procedures, voluntarily participate in breast cancer screening, and sign the informed consent. (4) Women who had previously participated in the "ultrasound-based breast cancer screening cohort study".
Exclusion criteria
Exclusion criteria: (1) Girls who have received HPV vaccine or have contraindications; (2) Women have received cervical cancer screening in the past 3 years, or with history of cervical cancer or precancerous lesions. (3) Women have received breast cancer screening in the past 3 years, or with history of breast cancer or precancerous lesion; pregnant women, breastfeeding women or women who are planning pregnancy.
Design outcomes
Secondary
| Measure | Time frame |
|---|---|
| Knowledge awareness rate;Colposcope recall rate;Follow-up rate; | — |
Primary
| Measure | Time frame |
|---|---|
| Coverage rate of cervical cancer screening;Coverage rate of breast cancer screening;Vaccination rate; | — |
Countries
China
Contacts
Public ContactQiao Youlin
School of Population Medicine and Public Health, Chinese Academy of Medical Sciences Peking Union Medical College
Outcome results
None listed